Engineered Nanoparticles for Drug Delivery in Cancer Therapy
The DOI matches its Crossref record; 579 of the 579 references it cites were found in a registry or an index.
Abstract
In medicine, nanotechnology has sparked a rapidly growing interest as it promises to solve a number of issues associated with conventional therapeutic agents, including their poor water solubility (at least, for most anticancer drugs), lack of targeting capability, nonspecific distribution, systemic toxicity, and low therapeutic index. Over the past several decades, remarkable progress has been made in the development and application of engineered nanoparticles to treat cancer more effectively. For example, therapeutic agents have been integrated with nanoparticles engineered with optimal sizes, shapes, and surface properties to increase their solubility, prolong their circulation half‐life, improve their biodistribution, and reduce their immunogenicity. Nanoparticles and their payloads have also been favorably delivered into tumors by taking advantage of the pathophysiological conditions, such as the enhanced permeability and retention effect, and the spatial variations in the pH value. Additionally, targeting ligands (e.g., small organic molecules, peptides, antibodies, and nucleic acids) have been added to the surface of nanoparticles to specifically target cancerous cells through selective binding to the receptors overexpressed on their surface. Furthermore, it has been demonstrated that multiple types of therapeutic drugs and/or diagnostic agents (e.g., contrast agents) could be delivered through the same carrier to enable combination therapy with a potential to overcome multidrug resistance, and real‐time readout on the treatment efficacy. It is anticipated that precisely engineered nanoparticles will emerge as the next‐generation platform for cancer therapy and many other biomedical applications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
In the citing paper
“Vasculature plays an essential role in the growth and metastasis of malignant tumors [103].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
Citations
Cites
Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism
Kresge, C. T., Leonowicz, M. E., Roth, W. J., Vartuli, J. C., & Beck, J. S. (1992) · Nature · doi:10.1038/359710a0 · Cited by 16,275
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Chemistry and Properties of Nanocrystals of Different Shapes
Burda, C., Chen, X., Narayanan, R., & El-Sayed, M. A. (2005) · Chemical Reviews · doi:10.1021/cr030063a · Cited by 7,230
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
Research works printed but not linked: 29
- Aruna U., 2013, Inter. J. Inn. Pharm. Res., 4, 318
- Langer R., 1998, Nature, 392, 5
- Petre C. E., 2007, Int. J. Nanomed., 2, 277
- Lao J., 2013, J. Drug Delivery, 456409
- Saif M. W., 2007, JOP, 8, 166
- Matsumura Y., 1986, Cancer Res., 46, 6387
- Xu G., 2001, Clin. Cancer Res., 7, 3314
- 10.1016/j.addr.2012.09.008 · doi:10.1016/j.addr.2012.09.008 · Paper page
- Pundir S., 2013, Int. J. Drug Res. Technol., 3, 12
- 10.1021/jp077468 · doi:10.1021/jp077468
- Mohanraj V. J., 2006, J. Pharm. Res., 5, 561
- Ma Y. D., 2011, Int. J. Nanomed., 6, 2679
- 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F · doi:10.1002/(sici)1097-4636(199908)46:2<236::aid-jbm13>3.0.co;2-f
- Krishna R., 2000, Eur. J. Cancer Sci., 11, 265
- Kettiger H., 2013, Int. J. Nanomed., 8, 3255
- Yuan F., 1995, Cancer Res., 55, 3752
- Jain R. K., 1987, Cancer Res., 47, 3039
- 10.1021/nn900002m · DOI · Paper page
- Chidambaram M., 2012, Int. J. Pharm. Sci., 2, 117
- 10.1039/C1CS15237H · DOI · Paper page
- 10.1038/nnano.2007.223 · DOI · Paper page
- Mohanraj V. J., 2006, Trop. J. Pharm. Res., 5, 561
- Hong R. L., 1999, Clin. Cancer Res., 5, 3645
- Shamsipour F., 2009, Avicenna J. Med. Biotechnol., 1, 27
- Park J. W., 2002, Clin. Cancer Res., 8, 1172
- Uppada S. B., 2014, Int. J. Nanomed., 9, 43
- Bangham A. D., 1965, J. Mol. Biol., 13, 227
- Mueller C., 1994, Methods Cell Sci., 16, 183
- 10.1016/j.cbpa.2005.10.005 · DOI
Cited by
Items 101–200 of 1,005
Wang, J., Li, W., Zhang, L., Ban, L., Chen, P., Du, W., Feng, X., & Liu, B.-F. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b06464 · Cited by 217
Light-Responsive Nanoparticles for Highly Efficient Cytoplasmic Delivery of Anticancer Agents
Wang, Y., Deng, Y., Luo, H., Zhu, A., Ke, H., Yang, H., & Chen, H. (2017) · ACS Nano · doi:10.1021/acsnano.7b05214 · Cited by 217
Tumor Microenvironment‐Enabled Nanotherapy
Wang, L., Huo, M., Chen, Y., & Shi, J. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701156 · Cited by 213
Ji, T., Zhao, Y., Ding, Y., Wang, J., Zhao, R., Lang, J., Qin, H., Liu, X., Shi, J., Tao, N., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201506262 · Cited by 215
Chen, D., Zhang, G., Li, R., Guan, M., Wang, X., Zou, T., Zhang, Y., Wang, C., Shu, C., Hong, H., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b12025 · Cited by 211
Self-citationNanomedicine: An effective tool in cancer therapy
Aftab, S., Shah, A., Nadhman, A., Kurbanoglu, S., Aysıl Ozkan, S., Dionysiou, D. D., Shukla, S. S., & Aminabhavi, T. M. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.02.007 · Cited by 208
Ouyang, C., Zhang, S., Xue, C., Yu, X., Xu, H., Wang, Z., Lu, Y., & Wu, Z.-S. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b09782 · Cited by 208
Nanoscale porous organic polymers for drug delivery and advanced cancer theranostics
Singh, N., Son, S., An, J., Kim, I., Choi, M., Kong, N., Tao, W., & Kim, J. S. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00559f · Cited by 208
Recent Developments in Antimicrobial-Peptide-Conjugated Gold Nanoparticles
Rajchakit, U., & Sarojini, V. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00368 · Cited by 204
Review on magnetic nanoparticle-mediated hyperthermia for cancer therapy
Rajan, A., & Sahu, N. K. (2020) · Journal of Nanoparticle Research · doi:10.1007/s11051-020-05045-9 · Cited by 204
“ticles (NPs) and its specific localization to the target site (Sun et al. 2014; Kauffman et al. 2015; Majumder et al. 2018; Alexis et al. 2008; Tang et al. 2009).”
BackgroundActive targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics
Shi, P., Cheng, Z., Zhao, K., Chen, Y., Zhang, A., Gan, W., & Zhang, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01826-1 · Cited by 200
“Active cellular targeting of nano-drug delivery systems is achieved by modifying high-affinity ligands or aptamers to target tumor cells and deliver antitumor drugs [81] (Fig.”
BackgroundSelf-citationNonviolent Self-Catabolic DNAzyme Nanosponges for Smart Anticancer Drug Delivery
Wang, J., Wang, H., Wang, H., He, S., Li, R., Deng, Z., Liu, X., & Wang, F. (2019) · ACS Nano · doi:10.1021/acsnano.9b01589 · Cited by 201
Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy
Li, W., Liu, Z., Fontana, F., Ding, Y., Liu, D., Hirvonen, J. T., & Santos, H. A. (2018) · Advanced Materials · doi:10.1002/adma.201703740 · Cited by 200
Gold Complexes in Anticancer Therapy: From New Design Principles to Particle‐Based Delivery Systems
Moreno‐Alcántar, G., Picchetti, P., & Casini, A. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202218000 · Cited by 200
Chen, F., Hableel, G., Zhao, E. R., & Jokerst, J. V. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.02.053 · Cited by 199
Biodegradable dendrimers for drug delivery
Huang, D., & Wu, D. (2018) · Materials Science and Engineering: C · doi:10.1016/j.msec.2018.03.002 · Cited by 197
Shen, G., Xing, R., Zhang, N., Chen, C., Ma, G., & Yan, X. (2016) · ACS Nano · doi:10.1021/acsnano.5b07276 · Cited by 196
Dong, Y., Li, W., Gu, Z., Xing, R., Ma, Y., Zhang, Q., & Liu, Z. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201904860 · Cited by 194
Cooperativity Principles in Self-Assembled Nanomedicine
Li, Y., Wang, Y., Huang, G., & Gao, J. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00195 · Cited by 191
“63,64 Living cells contain many such types of nanoscopic droplet-like structures from di ff erent compositions of biological molecules (Figure 6).”
Bunker, A., Magarkar, A., & Viitala, T. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2016.02.025 · Cited by 190
Ferrari, R., Sponchioni, M., Morbidelli, M., & Moscatelli, D. (2018) · Nanoscale · doi:10.1039/c8nr05933k · Cited by 189
Bauer, K. N., Tee, H. T., Velencoso, M. M., & Wurm, F. R. (2017) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2017.05.004 · Cited by 189
Liu, Y., An, S., Li, J., Kuang, Y., He, X., Guo, Y., Ma, H., Zhang, Y., Ji, B., & Jiang, C. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.060 · Cited by 188
Self-citationWang, S., Zhao, X., Wang, S., Qian, J., & He, S. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b05907 · Cited by 188
Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment
Cordani, M., & Somoza, Á. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2973-y · Cited by 188
Lin, L., Chi, J., Yan, Y., Luo, R., Feng, X., Zheng, Y., Xian, D., Li, X., Quan, G., Liu, D., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.014 · Cited by 182
Co-delivery of nitric oxide and antibiotic using polymeric nanoparticles
Nguyen, T.-K., Selvanayagam, R., Ho, K. K. K., Chen, R., Kutty, S. K., Rice, S. A., Kumar, N., Barraud, N., Duong, H. T. T., & Boyer, C. (2016) · Chemical Science · doi:10.1039/c5sc02769a · Cited by 187
Shen, S., Li, H.-J., Chen, K.-G., Wang, Y.-C., Yang, X.-Z., Lian, Z.-X., Du, J.-Z., & Wang, J. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b01193 · Cited by 186
Kankala, R. K., Zhang, H., Liu, C., Kanubaddi, K. R., Lee, C., Wang, S., Cui, W., Santos, H. A., Lin, K., & Chen, A. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201902652 · Cited by 184
Han, H., Valdepérez, D., Jin, Q., Yang, B., Li, Z., Wu, Y., Pelaz, B., Parak, W. J., & Ji, J. (2017) · ACS Nano · doi:10.1021/acsnano.6b05541 · Cited by 186
Chlorin e6: A Promising Photosensitizer in Photo-Based Cancer Nanomedicine
Hak, A., Ali, M. S., Sankaranarayanan, S. A., Shinde, V. R., & Rengan, A. K. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00891 · Cited by 182
Recent Development of Gold Nanoparticles as Contrast Agents for Cancer Diagnosis
Luo, D., Wang, X., Burda, C., & Basilion, J. P. (2021) · Cancers · doi:10.3390/cancers13081825 · Cited by 184
Nguyen, D. D., & Lai, J.-Y. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.134970 · Cited by 178
Chitosan magnetic nanoparticles for drug delivery systems
Assa, F., Jafarizadeh-Malmiri, H., Ajamein, H., Vaghari, H., Anarjan, N., Ahmadi, O., & Berenjian, A. (2017) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2016.1185389 · Cited by 183
“effects can be minimized.[1,2] In addition, it protects the”
BackgroundCell membrane-covered nanoparticles as biomaterials
Xuan, M., Shao, J., & Li, J. (2019) · National Science Review · doi:10.1093/nsr/nwz037 · Cited by 182
Kim, K., Lee, S., Jin, E., Palanikumar, L., Lee, J. H., Kim, J. C., Nam, J. S., Jana, B., Kwon, T.-H., Kwak, S. K., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b05736 · Cited by 181
Advances in silica based nanoparticles for targeted cancer therapy
Yang, Y., & Yu, C. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.10.018 · Cited by 183
Metal–Organic Polyhedron Capped with Cucurbit[8]uril Delivers Doxorubicin to Cancer Cells
Samanta, S. K., Moncelet, D., Briken, V., & Isaacs, L. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b09504 · Cited by 180
Sol-Gel Silica Nanoparticles in Medicine: A Natural Choice. Design, Synthesis and Products
Gonçalves, M. C. (2018) · Molecules · doi:10.3390/molecules23082021 · Cited by 179
Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions
Moradi Kashkooli, F., Jakhmola, A., Hornsby, T. K., Tavakkoli, J. (., & Kolios, M. C. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.02.009 · Cited by 177
Liu, W., Wang, Y.-M., Li, Y.-H., Cai, S.-J., Yin, X.-B., He, X.-W., & Zhang, Y.-K. (2017) · Small · doi:10.1002/smll.201603459 · Cited by 175
Self-citationJia, Q., Zheng, X., Ge, J., Liu, W., Ren, H., Chen, S., Wen, Y., Zhang, H., Wu, J., & Wang, P. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.05.005 · Cited by 174
Flexible Ferrofluids: Design and Applications
Zhang, X., Sun, L., Yu, Y., & Zhao, Y. (2019) · Advanced Materials · doi:10.1002/adma.201903497 · Cited by 174
Zhang, H., Ma, Y., Xie, Y., An, Y., Huang, Y., Zhu, Z., & Yang, C. J. (2015) · Scientific Reports · doi:10.1038/srep10099 · Cited by 174
Ge, R., Li, X., Lin, M., Wang, D., Li, S., Liu, S., Tang, Q., Liu, Y., Jiang, J., Liu, L., et al. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b07997 · Cited by 171
Sun, Y., & Davis, E. (2021) · Nanomaterials · doi:10.3390/nano11030746 · Cited by 165
Benyettou, F., Rezgui, R., Ravaux, F., Jaber, T., Blumer, K., Jouiad, M., Motte, L., Olsen, J.-C., Platas-Iglesias, C., Magzoub, M., et al. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00994d · Cited by 170
Potential applications of engineered nanoparticles in medicine and biology: an update
Rudramurthy, G. R., & Swamy, M. K. (2018) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-018-1600-6 · Cited by 171
Alsehli, M. (2020) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2020.01.004 · Cited by 170
“1) (Sun et al., 2014).”
Zhang, J., Liang, Y.-C., Lin, X., Zhu, X., Yan, L., Li, S., Yang, X., Zhu, G., Rogach, A. L., Yu, P. K. N., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b02513 · Cited by 169
Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment
Sonju, J. J., Dahal, A., Singh, S. S., & Jois, S. D. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.055 · Cited by 168
Strategies for Image-Guided Therapy, Surgery, and Drug Delivery Using Photoacoustic Imaging
Moore, C., & Jokerst, J. V. (2019) · Theranostics · doi:10.7150/thno.32362 · Cited by 169
“One important consideration for nanoparticle design is the size: typically, particles < 6 nm will be rapidly cleared by the kidneys, whereas particles > 8 nm cannot undergo glomerular filtration, and sizes between 30-200 nm can achieve long circulation times for enhanced accumulation and retention in tumors [69, 70].”
BackgroundChen, R., Zhang, J., Chelora, J., Xiong, Y., Kershaw, S. V., Li, K. F., Lo, P.-K., Cheah, K. W., Rogach, A. L., Zapien, J. A., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b12469 · Cited by 167
Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue
Gote, V., Nookala, A. R., Bolla, P. K., & Pal, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094673 · Cited by 166
“) route and have difficulty with effective dissolution and release of the drug from the tumor site [101,102].”
BackgroundSyntheses and biomedical applications of hollow micro-/nano-spheres with large-through-holes
Si, Y., Chen, M., & Wu, L. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00695c · Cited by 165
Kankala, R. K., Liu, C.-G., Chen, A.-Z., Wang, S.-B., Xu, P.-Y., Mende, L. K., Liu, C.-L., Lee, C.-H., & Hu, Y.-F. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00569 · Cited by 166
Facile Generation of Tumor‐pH‐Labile Linkage‐Bridged Block Copolymers for Chemotherapeutic Delivery
Sun, C., Liu, Y., Du, J., Cao, Z., Xu, C., & Wang, J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201509507 · Cited by 165
Nanoparticle–Protein Interactions: Therapeutic Approaches and Supramolecular Chemistry
Kopp, M., Kollenda, S., & Epple, M. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.7b00051 · Cited by 165
Advances in Carbon Based Nanomaterials for Bio-Medical Applications
Gupta, T. K., Budarapu, P. R., Chappidi, S. R., Y.B., S. S., Paggi, M., & Bordas, S. P. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666181126113605 · Cited by 165
Supramolecular cyclodextrin-based drug nanocarriers
Simões, S. M. N., Rey-Rico, A., Concheiro, A., & Alvarez-Lorenzo, C. (2015) · Chemical Communications · doi:10.1039/c4cc10388b · Cited by 164
Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications
Zangabad, P. S., Mirkiani, S., Shahsavari, S., Masoudi, B., Masroor, M., Hamed, H., Jafari, Z., Taghipour, Y. D., Hashemi, H., Karimi, M., et al. (2018) · Nanotechnology Reviews · doi:10.1515/ntrev-2017-0154 · Cited by 163
“The mechanism involves switching from nonpolar and more stable trans-isomer, to the more polar cis-isomer upon excitation with visible, UV, or even NIR wavelengths leading to drug release [85, 86, 88] (Figure 4B and C).”
BackgroundZhou, W., Jia, Y., Liu, Y., Chen, Y., & Zhao, P. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112346 · Cited by 178
Tammina, S. K., Mandal, B. K., Ranjan, S., & Dasgupta, N. (2017) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2016.11.017 · Cited by 159
He, H., Guo, C., Wang, J., Korzun, W. J., Wang, X.-Y., Ghosh, S., & Yang, H. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01892 · Cited by 158
Self-Assembled Peptide Drug Delivery Systems
Yang, J., An, H.-W., & Wang, H. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00707 · Cited by 160
Wang, C., Chen, S., Wang, Y., Liu, X., Hu, F., Sun, J., & Yuan, H. (2018) · Advanced Materials · doi:10.1002/adma.201706407 · Cited by 158
Towards principled design of cancer nanomedicine to accelerate clinical translation
Souri, M., Soltani, M., Moradi Kashkooli, F., Kiani Shahvandi, M., Chiani, M., Shariati, F. S., Mehrabi, M. R., & Munn, L. L. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100208 · Cited by 159
“As a result, in addition to reducing circulation time, clearance leads to reduced delivery of nanoparticles and drug to the tumor [40,41].”
BackgroundThanuja, M. Y., Anupama, C., & Ranganath, S. H. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.012 · Cited by 156
“level, surface properties, long circulation time, ability to cross biological barriers and reach specific cells/tissue, and controlled release [5, 6].”
BackgroundMashwani, Z., Khan, T., Khan, M. A., & Nadhman, A. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6987-1 · Cited by 162
Li, F., Li, T., Cao, W., Wang, L., & Xu, H. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.032 · Cited by 157
Advances in Lipid and Metal Nanoparticles for Antimicrobial Peptide Delivery
Makowski, M., Silva, Í. C., do Amaral, C. P., Gonçalves, S., & Santos, N. C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110588 · Cited by 162
“NPs between 100 and 200 nm can accumulate in the liver and further be eliminated by Kupffer cells [37,38].”
BackgroundYang, L., Sun, H. R., Liu, Y., Hou, W., Yang, Y. P., Cai, R., Cui, C., Zhang, P., Pan, X., Li, X., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201809753 · Cited by 159
Multifunctional nanoparticles: recent progress in cancer therapeutics
Raju, G. S. R., Benton, L., Pavitra, E., & Yu, J. S. (2015) · Chemical Communications · doi:10.1039/c5cc04643b · Cited by 165
Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics
Ehlerding, E. B., Grodzinski, P., Cai, W., & Liu, C. H. (2018) · ACS Nano · doi:10.1021/acsnano.7b07252 · Cited by 153
Targeting Cancer Stem Cells to Overcome Chemoresistance
Nunes, T., Hamdan, D., Leboeuf, C., El Bouchtaoui, M., Gapihan, G., Nguyen, T. T., Meles, S., Angeli, E., Ratajczak, P., Lu, H., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124036 · Cited by 153
Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer Treatment
Entzian, K., & Aigner, A. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081135 · Cited by 166
“On the other hand, polymeric coatings can alter the surface charge of liposomes and may have further benefits, such as increasing circulation time and targeting efficiency; thus, in some cases, improving the bioavailability of the encapsulated drug [109].”
BackgroundMicrofluidic Synthesis of Rigid Nanovesicles for Hydrophilic Reagents Delivery
Zhang, L., Feng, Q., Wang, J., Sun, J., Shi, X., & Jiang, X. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500096 · Cited by 151
Nanomedicines for Cancer Therapy: Current status, Challenges and Future Prospects
Bor, G., Azmi, I. D. M., & Yaghmur, A. (2019) · Therapeutic Delivery · doi:10.4155/tde-2018-0062 · Cited by 157
Subcellular Performance of Nanoparticles in Cancer Therapy
Liu, C., Han, Y., Kankala, R. K., Wang, S., & Chen, A. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s226186 · Cited by 160
“37,41 Despite their success, numerous formulations based on the organic materials have been withdrawn, and many struggling to pass further clinical translation procedures due to their intrinsic features of poor stability in the physiological fl uids and deprived drug encapsulation ef fi ciency.”
BackgroundGanguly, S., & Margel, S. (2022) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2022.101574 · Cited by 153
Cisplatin-Membrane Interactions and Their Influence on Platinum Complexes Activity and Toxicity
Martinho, N., Santos, T. C. B., Florindo, H. F., & Silva, L. C. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01898 · Cited by 161
“Besides its effects at the intracellular level, it is now recognized that cisplatin-induced cytotoxic events might start at the level of the PM, where it directly interacts with proteins and lipids, causing alterations in membrane structure (Sun et al., 2014; Senapati et al., 2018) and biophysical properties (Lacour e…”
BackgroundFischer, J., Beckers, S. J., Yiamsawas, D., Thines, E., Landfester, K., & Wurm, F. R. (2019) · Advanced Science · doi:10.1002/advs.201802315 · Cited by 149
Inorganic Nanoparticles Applied as Functional Therapeutics
Liu, Q., Kim, Y., Im, G., Zhu, J., Wu, Y., Liu, Y., & Bhang, S. H. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202008171 · Cited by 147
Functionalization of mixed ligand metal-organic frameworks as the transport vehicles for drugs
Sun, K., Li, L., Yu, X., Liu, L., Meng, Q., Wang, F., & Zhang, R. (2016) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2016.09.068 · Cited by 146
Current understanding of passive and active targeting nanomedicines to enhance tumor accumulation
Chen, Z., Kankala, R. K., Long, L., Xie, S., Chen, A., & Zou, L. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215051 · Cited by 155
Translatable High Drug Loading Drug Delivery Systems Based on Biocompatible Polymer Nanocarriers
Chen, W., Zhou, S., Ge, L., Wu, W., & Jiang, X. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00218 · Cited by 151
Two-dimensional transition metal dichalcogenide nanomaterials for combination cancer therapy
Gong, L., Yan, L., Zhou, R., Xie, J., Wu, W., & Gu, Z. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb00195a · Cited by 146
Cancer, Photodynamic Therapy and Porphyrin-Type Derivatives
Gomes, A. T. P. C., Neves, M. G. P. M. S., & Cavaleiro, J. A. S. (2018) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201820170811 · Cited by 153
Aggregation‐Induced Emission Luminogens: Union Is Strength, Gathering Illuminates Healthcare
Qi, J., Chen, C., Ding, D., & Tang, B. Z. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800477 · Cited by 142
A Review on Drug Delivery System for Tumor Therapy
Liu, G., Yang, L., Chen, G., Xu, F., Yang, F., Yu, H., Li, L., Dong, X., Han, J., Cao, C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.735446 · Cited by 170
“In recent years, many inorganic materials (nonmetallic and metal) and organic materials (natural polymers, liposomes, exosomes, and dendrimer) have been studied as delivery carriers and designed into multifunctional drug delivery systems with the best size, shape, and surface properties to optimize the antitumor effec…”
BackgroundHenry, N., Clouet, J., Bideau, J. L., Visage, C. L., & Guicheux, J. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.11.009 · Cited by 150
“Polymeric nanoparticles, liposomes, dendrimers, polymers, silicon or carbon materials, and magnetic nanoparticles are examples of nano-carriers used as drug delivery systems notably for cancer (Sun et al., 2014) or bone regeneration (van Rijt and Habibovic, 2017).”
Alshaer, W., Hillaireau, H., Vergnaud, J., Mura, S., Deloménie, C., Sauvage, F., Ismail, S. I., & Fattal, E. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.022 · Cited by 147
Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications
Darweesh, R. S., Ayoub, N. M., & Nazzal, S. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s223941 · Cited by 149
“Surface functionalization is used to introduce numerous biomolecules to the surface of AuNPs, such as peptides, proteins, and oligonucleotides.(60,61) For example, gold nanoclusters coated with a mixed monolayer of n-alkanethiol and tetraalkylammonium followed by DNA assembly on the surface of the AuNPs were used by M…”
MethodRecent Advances in Functionalized Nanoparticles in Cancer Theranostics
Siddique, S., & Chow, J. C. L. (2022) · Nanomaterials · doi:10.3390/nano12162826 · Cited by 139
“Now, functionalized NPs overcome those shortcomings and can also act as a contrast agent for diagnosis in therapeutic applications [89].”
BackgroundXu, Z., Liu, S., Kang, Y., & Wang, M. (2015) · Nanoscale · doi:10.1039/c5nr00297d · Cited by 140
Luo, L., Bian, Y., Liu, Y., Zhang, X., Wang, M., Xing, S., Li, L., & Gao, D. (2016) · Small · doi:10.1002/smll.201503961 · Cited by 145
Tumour microenvironment responsive nanoconstructs for cancer theranostic
Gulzar, A., Xu, J., Wang, C., He, F., Yang, D., Gai, S., Yang, P., Lin, J., Jin, D., & Xing, B. (2019) · Nano Today · doi:10.1016/j.nantod.2019.03.007 · Cited by 139
Wang, H., Xie, H., Wang, J., Wu, J., Ma, X., Li, L., Wei, X., Ling, Q., Song, P., Zhou, L., et al. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501953 · Cited by 138
Photoactivated Polymersome Nanomotors: Traversing Biological Barriers
Shao, J., Cao, S., Williams, D. S., Abdelmohsen, L. K. E. A., & van Hest, J. C. M. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202003748 · Cited by 143
Cancer Therapy by Silver Nanoparticles: Fiction or Reality?
Kovács, D., Igaz, N., Gopisetty, M. K., & Kiricsi, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020839 · Cited by 161
“The internal niche of the tumors is slightly acidic compared to that of normal tissues [57], and this difference in pH can affect the nanoparticle–stroma interaction.”
Background
Metadata
- Authors
- Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y.
- Affiliations
- Georgia Institute of Technology (US)
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2014-10-07
- Volume
- 53
- Issue
- 46
- Pages
- 12320-12364
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2134726513
- Cited by
- 2,164
- References
- 578
- Citations by year
- 2026: 57 · 2025: 146 · 2024: 163 · 2023: 153 · 2022: 209 · 2021: 200 · 2020: 221 · 2019: 237 · 2018: 257 · 2017: 230 · 2016: 180 · 2015: 109 · 2014: 2
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Angewandte Chemie International Edition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- engineered nanoparticles, drug delivery, cancer therapy, targeted drug delivery, enhanced permeability and retention effect, pH-responsive delivery, tumor-targeting ligands, tissue distribution, circulation half-life, immunogenicity, combination therapy, multidrug resistance, contrast media, theranostics, nanoparticle surface modification
- MeSH terms
- Animals, Antineoplastic Agents, Delayed-Action Preparations, Humans, Neoplasms, Drug Delivery Systems, Nanotechnology, Nanomedicine, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.